Copay help by condition · Heart and circulation · read 2026-11-08
Pulmonary Arterial Hypertension: which charitable copay funds are open
The one fund we hold for Pulmonary Arterial Hypertension is closed or at capacity right now (read 2026-11-08).
Funds fill and reopen. Use the alert below, ask the manufacturer's program for your drug (see the assistance finder), and check your state's Medicaid coverage.
If you have Medicare Part D: CMS prints the annual out-of-pocket threshold as $2,400 in 2027 ($2,100 in 2026) (Table V-2 of its CY 2027 announcement). It is a benefit parameter and applies to covered drugs under plan rules. What changes on January 1.
Swipe to read across
A copy for a patient, a clinic or a pharmacist, with each source and the date we read it.
Every fund we hold for Pulmonary Arterial Hypertension
- Closed or at capacityPulmonary Arterial Hypertension
Good Days ·
Award level: not statedInsurance supported: not stated
The page marks the fund as not currently open for new enrollments (the fund's list item on the page carries the class closed). Source page
Drugs whose FDA label names Pulmonary Arterial Hypertension
5 drugs. Each row quotes the sentence of the drug's FDA label (Indications and Usage, openFDA) that names the condition. A label naming a condition is not a statement that the drug is approved, effective or covered for you. Dashes in quotes are shown as hyphens. Of these, 4 have a program (in our assistance finder or on the program's own page) and 0 have a Medicare negotiated price in the CMS file; an empty cell says we found nothing in our data, not that nothing exists.
| Drug | What the FDA label says | Manufacturer program | Medicare negotiated price |
|---|---|---|---|
| Opsumit Macitentan Every route for this drug | OPSUMIT is an endothelin receptor antagonist (ERA) indicated for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) in adults to reduce the risks of disease progression and hospitalization for PAH ( 1. Label on openFDA, read 2026-11-10 | Johnson & Johnson Patient Assistance Program | not in the CMS negotiated-price file |
| Adempas Riociguat Every route for this drug | Pulmonary Arterial Hypertension (PAH) (WHO Group 1) to improve exercise capacity, improve WHO functional class and to delay clinical worsening. Label on openFDA, read 2026-11-10 | Bayer US Patient Assistance Foundation (program page) | not in the CMS negotiated-price file |
| Uptravi Selexipag Every route for this drug | UPTRAVI is a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension (PAH, WHO Group I): In adults to delay disease progression and reduce the risk of hospitalization for PAH. Label on openFDA, read 2026-11-10 | Johnson & Johnson Patient Assistance Program | not in the CMS negotiated-price file |
| Winrevair Sotatercept-Csrk Every route for this drug | WINREVAIR™ is indicated for the treatment of adults with pulmonary arterial hypertension (PAH, Group 1 pulmonary hypertension) to improve exercise capacity and World Health Organization (WHO) functional class (FC), and reduce the risk of clinical ... Label on openFDA, read 2026-11-10 | Merck Patient Assistance Program | not in the CMS negotiated-price file |
| Tyvaso Dpi Treprostinil | Treatment of pulmonary arterial hypertension (PAH; Label on openFDA, read 2026-11-10 | not in our assistance finder | not in the CMS negotiated-price file |
Related conditions
Group: Heart and circulation. All conditions: the condition index. Fund board for every condition: charitable copay fund status.
What changed
First read on 2026-11-08. We keep each read with its date, so a fund reopening or closing will show here as a change. Until we have a second read there is nothing to compare, and we do not guess. The read date of every source is on the changes page.
This page as data
The same facts as JSON, each fund with its source URL and read date: pulmonary-arterial-hypertension.json. Edition 2026-11, root 006ab9a329709cbe. See the licence page.
Questions
Is there an open charitable copay fund for Pulmonary Arterial Hypertension?
As read on 2026-11-08, none of the 1 funds we hold for Pulmonary Arterial Hypertension say they are open. Funds reopen, so use the alert on this page.
Which organizations run funds for Pulmonary Arterial Hypertension?
Good Days. Each fund row on this page links to the organization's own page.
Does an open fund mean I qualify?
No. A status says whether a fund is taking applications. Eligibility, award level and which insurance it supports are each fund's own rules; where the page states them they are shown on the fund.
How current is this page?
Statuses are what each fund's own page said on the date we read it (2026-11-08). We do not promise a fund is still in that state today.